NEVRO CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.39 USD | 0.00% |
|
-17.63% | -56.37% |
Chart calendar Nevro Corp.
c4248b35a494f79f12c0eafd99.mRnvmvFY-WXPFzfDYYS0HjUfWHktQY-wLQqjWjn54pQ._Gje8cEIoA6pW2-2Nsf6bH1ybQBLLfjEXG_pMl7BqNXhdbXFwyKPH6RyBw~605a8582f4c3091bb0232e38fbf50869
Upcoming events on Nevro Corp.
Past events on Nevro Corp.
| 2024-05-23 01:30 pm | Annual General Meeting |
| 2024-05-14 12:20 pm | BofA Securities Health Care Conference |
| 2024-05-07 04:30 pm | Q1 2024 Earnings Call |
| 2024-05-07 04:05 pm | Q1 2024 Earnings Release |
| 2024-02-21 04:30 pm | Q4 2023 Earnings Call |
| 2024-02-21 04:05 pm | Q4 2023 Earnings Release |
| 2024-01-20 08:14 pm | North American Neuromodulation Society Meeting - Leonardo Kapural, M.D. |
| 2024-01-20 | North American Neuromodulation Society Meeting - Neuromodulation and Athletics. Parallels and Lesson |
| 2024-01-20 05:15 pm | North American Neuromodulation Society Meeting - Johnathan Goree, M.D. |
| 2024-01-20 04:30 pm | North American Neuromodulation Society Meeting |
| 2024-01-20 03:00 pm | North American Neuromodulation Society Meeting - Lunch Symposium |
| 2024-01-20 02:12 pm | North American Neuromodulation Society Meeting - Dongchul Lee |
| 2024-01-20 01:40 pm | North American Neuromodulation Society Meeting - David Caraway, M.D. |
| 2024-01-20 01:30 pm | North American Neuromodulation Society Meeting - Scientific Advances in Neuromodulation Session |
| 2024-01-11 11:15 am | J.P. Morgan Healthcare Conference |
| 2023-11-01 04:30 pm | Q3 2023 Earnings Call |
| 2023-11-01 04:01 pm | Q3 2023 Earnings Release |
| 2023-09-11 12:55 pm | Morgan Stanley Global Healthcare Conference |
| 2023-09-07 04:30 pm | Wells Fargo Healthcare Conference |
| 2023-08-09 08:30 am | Canaccord Genuity Growth Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 390 388 0.6% | 362 360 0.68% | 387 385 0.61% | 406 406 0.01% | 425 425 0.05% | 440 |
|
EBITDA Million USD | Released Forecast Spread | -82,0 -85,9 4.51% | -3,86 -15,3 74.82% | -17,2 -21,3 19.35% | -23,8 -21,6 -10.17% | -17,7 -24,2 26.89% | -1,77 |
|
EBIT Million USD | Released Forecast Spread | -86,7 -95,4 9.07% | -62,9 -68,9 8.73% | -111 -106 -4.91% | 6,16 8,90 -30.72% | -99,3 -105 5.25% | -88,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -102 -101 -1.02% | -82,2 -86,3 4.8% | -131 -117 -11.97% | 4,26 -23,0 118.55% | -97,9 -99,6 1.75% | -82,0 |
|
Net income Million USD | Released Forecast Spread | -104 -110 5.7% | -83,1 -87,4 5.01% | -131 -125 -5.35% | 3,00 -14,7 120.4% | -92,2 -101 8.95% | -84,0 |
|
EPS USD | Released Forecast Spread | -3,37 -3,58 5.97% | -2,47 -2,61 5.34% | -3,77 -3,63 -3.75% | 0,08 -0,78 110.26% | -2,56 -2,81 8.98% | -2,31 |
| Announcement Date | 25/02/20 | 24/02/21 | 23/02/22 | 16/02/23 | 21/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 87,8 86,2 1.92% | 104 104 -0.25% | 100 99,2 1.32% | 114 114 0.13% | 96,3 95,4 1.02% | 109 108 0.69% | 104 95,9 8.32% | 116 116 0.16% | 102 97,9 4.05% | 107 | 108 | 123 | 107 | 114 |
|
EBITDA Million USD | Released Forecast Spread | -14,1 -19,7 28.61% | -4,49 -6,68 32.77% | -3,80 -7,74 50.99% | -1,44 1,08 -233.55% | -17,1 -20,0 14.45% | -3,13 -4,84 35.49% | -5,80 -9,23 37.24% | 8,37 1,19 605.35% | -9,60 -15,6 38.52% | -2,80 | -0,71 | 10,7 | -10,6 | -0,41 |
|
EBIT Million USD | Released Forecast Spread | -32,8 -35,5 7.82% | -23,8 -25,3 6.07% | 82,1 4,98 1547.06% | -19,4 -17,0 -13.62% | -36,3 -36,5 0.59% | -25,6 -24,8 -3.46% | -25,6 -28,1 8.98% | -11,8 -18,2 35.15% | -35,8 -36,1 0.62% | -24,5 | -20,6 | -10,4 | -30,9 | -20,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -34,1 -37,9 9.82% | -24,7 -27,3 9.2% | 82,0 16,3 403% | -18,8 -17,9 -5.14% | -34,7 -37,0 6.31% | -24,2 -23,9 -1.39% | -23,3 -28,7 18.78% | -15,6 -17,4 10.56% | -25,0 -38,4 34.82% | -26,4 | -22,0 | -12,2 | -32,5 | -23,3 |
|
Net income Million USD | Released Forecast Spread | -34,3 -38,8 11.55% | -25,0 -28,0 10.7% | 81,5 7,33 1011.34% | -19,2 -18,1 -6.04% | -35,0 -37,2 5.76% | -24,7 -24,5 -1.01% | -23,5 -27,8 15.45% | -8,98 -17,6 49.05% | -25,4 -38,8 34.43% | -26,0 | -21,9 | -11,7 | -31,6 | -23,6 |
|
EPS USD | Released Forecast Spread | -0,98 -1,10 10.96% | -0,71 -0,80 11.58% | 2,22 -0,10 2391.49% | -0,54 -0,49 -10.58% | -0,98 -1,04 5.69% | -0,69 -0,69 0.15% | -0,65 -0,77 15.49% | -0,25 -0,49 48.96% | -0,70 -1,05 33.55% | -0,70 | -0,58 | -0,31 | -0,80 | -0,61 |
| Announcement Date | 04/05/22 | 03/08/22 | 02/11/22 | 16/02/23 | 26/04/23 | 01/08/23 | 01/11/23 | 21/02/24 | 07/05/24 | - | - | - | - | - |
| 2024-05-28 05:00 pm | FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED: Q4 2024 Earnings Release |
| 2024-05-31 08:00 am | MESA LABORATORIES, INC.: Q4 2024 Earnings Release |
| 2024-06-18 | PATTERSON COMPANIES, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-06-26 | SCHOTT PHARMA AG & CO. KGAA: Q2 2024 Earnings Release |
| 2024-07-03 | MANI, INC.: Q3 2024 Earnings Release (Projected) |
| 2024-07-11 01:00 am | GERRESHEIMER AG: Q2 2024 Earnings Release |
| 2024-07-11 | ARJO AB: Q2 2024 Earnings Release |
| 2024-07-12 01:30 am | XVIVO PERFUSION AB: Q2 2024 Earnings Release |
| 2024-07-17 | ABBOTT LABORATORIES: Q2 2024 Earnings Release (Projected) |
| 2024-07-17 | MEDMIX AG: Q2 2024 Earnings Release |
Past sector events for Nevro Corp.
| 2024-05-23 06:45 am | MEDTRONIC PLC: Q4 2024 Earnings Release |
| 2024-05-22 01:00 am | YPSOMED HOLDING AG: Q4 2024 Earnings Release |
| 2024-05-17 04:19 am | POLY MEDICURE LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 02:00 am | CONVATEC GROUP PLC: Q1 2024 Sales and Revenue Release - Trading Update |
| 2024-05-14 | HOYA CORPORATION: Q4 2023 Earnings Release |
| 2024-05-14 01:00 am | AMBU A/S: Q2 2024 Earnings Release |
| 2024-05-13 | HLB CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-05-13 | TERUMO CORPORATION: Q4 2024 Earnings Release |
| 2024-05-13 | ALFRESA HOLDINGS CORPORATION: Q4 2023 Earnings Release |
| 2024-05-12 | PARAMOUNT BED HOLDINGS CO., LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NVRO Stock
- Calendar Nevro Corp.
